pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
NTCDM-3
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Destiny Pharma Ltd
0 catalysts
Phase 2
NTM-006
Post-Operative Pain
Neumentum Inc
0 catalysts
Phase 2
NTX-1472
Social Anxiety Disorder (SAD/Social Phobia)
Newleos Therapeutics Inc
0 catalysts
Phase 2
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
← prev
page 20 of 50
next →
131
Pain89
Neurology1
Pinotbio Inc
0 catalysts
Phase 2
NVG-291
Chronic Spinal Cord Injury
$NGENNERVGEN PHARMA CORP.
0 catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0 catalysts
Phase 2
NX-210c
Amyotrophic Lateral Sclerosis
Axoltis Pharma SAS
0 catalysts
Phase 2
NanoDOX
Wounds
Resilience Government Services Inc
0 catalysts
Phase 2
Nerofe
Refractory Acute Myeloid Leukemia
Immune System Key Ltd
0 catalysts
Phase 2
Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
Norovirus Infections
$VXRTVaxart, Inc.
0 catalysts
Phase 2
NouvNeu-001
Parkinson's Disease
iRegene Therapeutics Co Ltd
0 catalysts
Phase 2
Nov-DB2
Obesity
NovMetaPharma Co Ltd
0 catalysts
Phase 2
NovOB
Obesity
DNA gyrase
NovMetaPharma Co Ltd
0 catalysts
Phase 2
NovoCardia
Congestive Heart Failure (Heart Failure)
Help Therapeutics
0 catalysts
Phase 2
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
0 catalysts
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
0 catalysts
Phase 2
OA-SYS
Osteoarthritis
Ageless Biotech Inc
0 catalysts
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
0 catalysts
Phase 2
OBI-902
Bile Duct Cancer (Cholangiocarcinoma)
OBI Pharma Inc
0 catalysts
Phase 2
OBX-115
Metastatic Melanoma
Obsidian Therapeutics Inc
0 catalysts
Phase 2
OCU-410
Geographic Atrophy
$OCGNOcugen, Inc.
0 catalysts
Phase 2
OLX-101A
Hypertrophic Scars
OliX Pharmaceuticals Inc
0 catalysts
Phase 2
OMO-1
Solid Tumor
DeuterOncology NV
0 catalysts
Phase 2
ONC-841
Colorectal Cancer
OncoC4 Inc
0 catalysts
Phase 2
ONO-2020
Alzheimer's Disease
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPC-1
Acute Spinal Cord Injury
5-hydroxytryptamine receptor 2AD(2) dopamine receptor
$LCTXLineage Cell Therapeutics, Inc.
0 catalysts
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
0 catalysts
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPGx-BEST1
Macular Degeneration
$IRDOpus Genetics, Inc.
0 catalysts